Astria Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2016 to Q4 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Astria Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2016 to Q4 2024.
  • Astria Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2024 was 2.28K %, a 9.65% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 2.28K -243 -9.65% Dec 31, 2024
Q3 2024 2.44K -205 -7.76% Sep 30, 2024
Q2 2024 2.43K -234 -8.78% Jun 30, 2024
Q1 2024 2.65K +217 +8.94% Mar 31, 2024
Q4 2023 2.52K +325 +14.8% Dec 31, 2023
Q3 2023 2.65K +523 +24.6% Sep 30, 2023
Q2 2023 2.66K +276 +11.5% Jun 30, 2023
Q1 2023 2.43K -307 -11.2% Mar 31, 2023
Q4 2022 2.2K -806 -26.9% Dec 31, 2022
Q3 2022 2.12K -282 -11.7% Sep 30, 2022
Q2 2022 2.39K +597 +33.3% Jun 30, 2022
Q1 2022 2.74K +1.43K +109% Mar 31, 2022
Q4 2021 3K +2.09K +228% Dec 31, 2021
Q3 2021 2.4K +1.47K +157% Sep 30, 2021
Q2 2021 1.79K +850 +90.5% Jun 30, 2021
Q1 2021 1.31K +397 +43.5% Mar 31, 2021
Q4 2020 914 +10.3 +1.14% Dec 31, 2020
Q3 2020 937 -7.14 -0.76% Sep 30, 2020
Q2 2020 940 -91.2 -8.85% Jun 30, 2020
Q1 2020 913 -151 -14.2% Mar 31, 2020
Q4 2019 904 +83.5 +10.2% Dec 31, 2019
Q3 2019 944 +303 +47.3% Sep 30, 2019
Q2 2019 1.03K +574 +125% Jun 30, 2019
Q1 2019 1.06K +736 +225% Mar 31, 2019
Q4 2018 820 +466 +132% Dec 31, 2018
Q3 2018 641 +243 +61% Sep 30, 2018
Q2 2018 457 -7.23 -1.56% Jun 30, 2018
Q1 2018 328 -189 -36.6% Mar 31, 2018
Q4 2017 354 -229 -39.3% Dec 31, 2017
Q3 2017 398 -272 -40.6% Sep 30, 2017
Q2 2017 464 -314 -40.4% Jun 30, 2017
Q1 2017 517 -390 -43% Mar 31, 2017
Q4 2016 583 Dec 31, 2016
Q3 2016 670 Sep 30, 2016
Q2 2016 779 Jun 30, 2016
Q1 2016 907 Mar 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.